PubMed COVID-19 Clinical Care

No abstract

Thermal elemental carbon (EC), optical black carbon (BC), organic carbon (OC), mineral dust (MD), and 7-wavelength optical attenuation of 24-hour ambient PM(2.5) samples were characterized/estimated at a regionally representative site (Bhopal

Tuberculosis is a major health issue globally and a leading cause of death due to the infective microorganism Mycobacterium tuberculosis. Treatment of drug resistance tuberculosis requires longer treatment with multiple daily doses of drugs

CONCLUSIONS: There was significant decline in overall industry payments coinciding with the COVID pandemic, with biggest declines in gifts and speaker fees. The impact on the different categories of payments and recovery in the last two years has

No abstract

Favipiravir (FVP) is a broad-spectrum antiviral that selectively inhibits viral RNA-dependent RNA polymerase, first trialled for the treatment of influenza infection. It has been shown to be effective against a number of RNA virus families including

No abstract

CONCLUSION: The incidence of secondary bacterial infections was high in critically ill patients with COVID-19 and was associated with a longer duration of admission to the hospital and ICU and a higher mortality. Diabetes mellitus and cumulative dose

Systemic corticosteroid is considered effective in treating severe or critical coronavirus disease 2019 (COVID-19) patients in both Chinese and international consensus and/or guidelines. Dexamethasone (6 mg daily for up to 10 days) is usually

BACKGROUND: Convalescent plasma (CP) transfusion is an early option for treating infections with pandemic potential, often preceding vaccine or antiviral drug rollout. Heterogenous findings from randomized clinical trials on transfusion of COVID-19